Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Ototoxicity potential of multiple antimicrobial agents in a validated animal model

EF 2022-23

Résumé
Chronic otorrhea is one of many complications of acute otitis media, a common middle ear infection that will affect 60 to 70% of children under the age of 3. It is characterized by the constant discharge of fluids coming from the ears and caused by multiple bacteria and fungi. The World Health Organization estimates that between 65 and 330 million patients suffer from this condition. It can signal a more serious ear infection that, if left untreated, can result in deafness, cranial nerve dysfunctions, and meningitis. Additionally, children who typically wear hearing aids are unable to do so due to the presence of fluid, which can greatly affect their language development and psychosocial skills. Antibiotic ear drops are the most common treatment, but choices are limited. The literature lacks studies that use a combination of antibiotic and antifungal agents to treat chronic otorrhea. Additionally, the ototoxicity many of those agents has not yet been determined. Our objective is to investigate the ototoxicity of multiple antimicrobial agents to establish their safety as a treatment option for chronic otorrhea. We will achieve this by using a well-established, validated animal model with similar ear structures to humans. We will have separate groups to test each antimicrobial agent. Over the course of 4 weeks, we will apply the antimicrobial agent in one ear and saline in the other to compare their functioning. Ototoxicity will be evaluated by analyzing hearing evaluation taken at various intervals throughout the project and histological analysis of the inner ear structures. Establishing the safety of these antimicrobial agents will allow physicians to better treat chronic otorrhea by targeting a wider range of the causative bacteria and fungi.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486187
Name
Théorêt Karina
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Ototoxicity potential of multiple antimicrobial agents in a validated animal model
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Acute Otitis Media; Animal Model; Antibiotic Treatment; Antifungal Treatment; Chronic Otorrhea; Middle Ear Infection; Otolaryngology; Otology; Ototoxicity; Topical Application
Abstract
Chronic otorrhea is one of many complications of acute otitis media, a common middle ear infection that will affect 60 to 70% of children under the age of 3. It is characterized by the constant discharge of fluids coming from the ears and caused by multiple bacteria and fungi. The World Health Organization estimates that between 65 and 330 million patients suffer from this condition. It can signal a more serious ear infection that, if left untreated, can result in deafness, cranial nerve dysfunctions, and meningitis. Additionally, children who typically wear hearing aids are unable to do so due to the presence of fluid, which can greatly affect their language development and psychosocial skills. Antibiotic ear drops are the most common treatment, but choices are limited. The literature lacks studies that use a combination of antibiotic and antifungal agents to treat chronic otorrhea. Additionally, the ototoxicity many of those agents has not yet been determined. Our objective is to investigate the ototoxicity of multiple antimicrobial agents to establish their safety as a treatment option for chronic otorrhea. We will achieve this by using a well-established, validated animal model with similar ear structures to humans. We will have separate groups to test each antimicrobial agent. Over the course of 4 weeks, we will apply the antimicrobial agent in one ear and saline in the other to compare their functioning. Ototoxicity will be evaluated by analyzing hearing evaluation taken at various intervals throughout the project and histological analysis of the inner ear structures. Establishing the safety of these antimicrobial agents will allow physicians to better treat chronic otorrhea by targeting a wider range of the causative bacteria and fungi.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Théorêt, Karina
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~